1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Europe Therapeutic Vaccines Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Europe Therapeutic Vaccines Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Europe Therapeutic Vaccines Market Regional Analysis
6.2 Europe Therapeutic Vaccines Market Revenue 2021-2031 (US$ Thousand)
6.3 Europe Therapeutic Vaccines Market Forecast Analysis
7. Europe Therapeutic Vaccines Market Analysis – by Product
7.1 Cancer Vaccine
- 7.1.1 Overview
- 7.1.2 Cancer Vaccine: Europe Therapeutic Vaccines Market – Revenue and Forecast, 2021-2031 (US$ Thousand)
7.2 Infectious Disease Vaccine
- 7.2.1 Overview
- 7.2.2 Infectious Disease Vaccine: Europe Therapeutic Vaccines Market – Revenue and Forecast, 2021-2031 (US$ Thousand)
7.3 Others
- 7.3.1 Overview
- 7.3.2 Others : Europe Therapeutic Vaccines Market – Revenue and Forecast, 2021-2031 (US$ Thousand)
8. Europe Therapeutic Vaccines Market Analysis – by Technology
8.1 Allogenic Vaccine and Autologus Vaccine
- 8.1.1 Overview
- 8.1.2 Allogenic Vaccine and Autologus Vaccine: Europe Therapeutic Vaccines Market – Revenue and Forecast, 2021-2031 (US$ Thousand)
9. Europe Therapeutic Vaccines Market Analysis – by End User
9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Hospitals: Europe Therapeutic Vaccines Market – Revenue and Forecast, 2021-2031 (US$ Thousand)
9.2 Clinics
- 9.2.1 Overview
- 9.2.2 Clinics: Europe Therapeutic Vaccines Market – Revenue and Forecast, 2021-2031 (US$ Thousand)
9.3 Others
- 9.3.1 Overview
- 9.3.2 Others : Europe Therapeutic Vaccines Market – Revenue and Forecast, 2021-2031 (US$ Thousand)
10. Europe Therapeutic Vaccines Market – Europe Analysis
10.1 Overview
10.2 Europe
- 10.2.1 Europe Therapeutic Vaccines Market Breakdown, by Key
Country, 2024 and 2031 (%)
- 10.2.1.1 Europe Therapeutic Vaccines Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 Germany:
Europe Therapeutic Vaccines Market – Revenue and Forecast to 2031 (US$ Thousand)
- 10.2.1.1.1 Germany: Europe Therapeutic Vaccines Market Breakdown, by Product
- 10.2.1.1.2 Germany: Europe Therapeutic Vaccines Market Breakdown, by Technology
- 10.2.1.1.3 Germany: Europe Therapeutic Vaccines Market Breakdown, by End User
- 10.2.1.2 France:
Europe Therapeutic Vaccines Market – Revenue and Forecast to 2031 (US$ Thousand)
- 10.2.1.2.1 France: Europe Therapeutic Vaccines Market Breakdown, by Product
- 10.2.1.2.2 France: Europe Therapeutic Vaccines Market Breakdown, by Technology
- 10.2.1.2.3 France: Europe Therapeutic Vaccines Market Breakdown, by End User
- 10.2.1.3 UK:
Europe Therapeutic Vaccines Market – Revenue and Forecast to 2031 (US$ Thousand)
- 10.2.1.3.1 UK: Europe Therapeutic Vaccines Market Breakdown, by Product
- 10.2.1.3.2 UK: Europe Therapeutic Vaccines Market Breakdown, by Technology
- 10.2.1.3.3 UK: Europe Therapeutic Vaccines Market Breakdown, by End User
- 10.2.1.4 Russia:
Europe Therapeutic Vaccines Market – Revenue and Forecast to 2031 (US$ Thousand)
- 10.2.1.4.1 Russia: Europe Therapeutic Vaccines Market Breakdown, by Product
- 10.2.1.4.2 Russia: Europe Therapeutic Vaccines Market Breakdown, by Technology
- 10.2.1.4.3 Russia: Europe Therapeutic Vaccines Market Breakdown, by End User
- 10.2.1.5 Italy:
Europe Therapeutic Vaccines Market – Revenue and Forecast to 2031 (US$ Thousand)
- 10.2.1.5.1 Italy: Europe Therapeutic Vaccines Market Breakdown, by Product
- 10.2.1.5.2 Italy: Europe Therapeutic Vaccines Market Breakdown, by Technology
- 10.2.1.5.3 Italy: Europe Therapeutic Vaccines Market Breakdown, by End User
- 10.2.1.6 Spain:
Europe Therapeutic Vaccines Market – Revenue and Forecast to 2031 (US$ Thousand)
- 10.2.1.6.1 Spain: Europe Therapeutic Vaccines Market Breakdown, by Product
- 10.2.1.6.2 Spain: Europe Therapeutic Vaccines Market Breakdown, by Technology
- 10.2.1.6.3 Spain: Europe Therapeutic Vaccines Market Breakdown, by End User
- 10.2.1.7 Rest of Europe:
Europe Therapeutic Vaccines Market – Revenue and Forecast to 2031 (US$ Thousand)
- 10.2.1.7.1 Rest of Europe: Europe Therapeutic Vaccines Market Breakdown, by Product
- 10.2.1.7.2 Rest of Europe: Europe Therapeutic Vaccines Market Breakdown, by Technology
- 10.2.1.7.3 Rest of Europe: Europe Therapeutic Vaccines Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Dendreon
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 BioNTech SE
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Serum Institute of India Pvt. Ltd
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Merck & Co Inc
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Amgen Inc
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 ISA Pharmaceuticals BV
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 INOVIO Pharmaceuticals Inc
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Transgene SA
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 THERAVECTYS SA
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 CureVac SE
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations
Get Free Sample For Europe Therapeutic Vaccines Market
